Australian antiviral drug development company Island Pharmaceuticals has reallocated US government funding to support its planned ISLA-101 Phase 2a human clinical trial in dengue fever. …
Island announces reallocation of US grant funding to support dengue fever trial
May 8, 2024 Latest NewsAustralian Biotech
Latest Video
New Stories
-
Can we just have an honest conversation about Budget and reform
May 20, 2024 - - Podcast -
Health department makes a major change inside critical division
May 17, 2024 - - Latest News -
Baxter launches the mission and logo of new kidney care company
May 16, 2024 - - Latest News -
NZ Prime Minister says, 'We are recognising that we have a problem'
May 16, 2024 - - Latest News -
Generic and biosimilar sector welcomes the Government's 'cost of living' Budget
May 16, 2024 - - Latest News -
Budget provides minimal support for projects to build APS capability
May 16, 2024 - - Latest News -
Mark Butler establishes a place in history by ruling out new PBS savings measures
May 16, 2024 - - Latest News